Zenlabs Ethica Limited (ZENLABS.BO)
INR 40.85
(0.59%)
INR 40.85
(0.59%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -90.6 Million | 15.19 Million | -3.82 Million | -84.11 Million | 4.53 Million |
| Net Income | 5.81 Million | 6.74 Million | 12.21 Million | 8.6 Million | -7.32 Million |
| Depreciation & Amortization | 12.94 Million | 12.51 Million | 8.91 Million | 7.14 Million | 6.84 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | -116.19 Million | -11.67 Million | -26.57 Million | -100.97 Million | 8.74 Million |
| Other non-cash items | 7.75 Million | 10.25 Million | 2.86 Million | 1.92 Million | -3.73 Million |
| Investing Cash Flow | 1.09 Million | -14.68 Million | 15 Thousand | 1.54 Million | 51.58 Thousand |
| Investments in PPE | -221 Thousand | -15.46 Million | -272 Thousand | -16 Thousand | -534.43 Thousand |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - |
| Other Investing Activities | 1.31 Million | 783 Thousand | 287 Thousand | 1000.00 | 10.00 |
| Financing Cash Flow | 82.38 Million | 603 Thousand | 3.13 Million | -5.23 Million | -323.44 Thousand |
| Debt repayment | -100.22 Million | -16.05 Million | -11.12 Million | -908 Thousand | -453.84 Thousand |
| Dividends payments | - | -1.62 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - |
| Other Financing Activities | 97.79 Million | 2.61 Million | 12 Million | -10.00 | 10.00 |
| Accounts receivables | 9.38 Million | -15.28 Million | -18.62 Million | 33.63 Million | - |
| Accounts payables | - | - | - | - | - |
| Inventory | -6.26 Million | -27.13 Million | -34.7 Million | -5.79 Million | - |
| Other working capital | 13.47 Million | -5.07 Million | 781 Thousand | -160.42 Million | 8.74 Million |
| Cash at beginning of period | 16.18 Million | 15.06 Million | 15.73 Million | 103.54 Million | 16.66 Million |
| Cash at end of period | 9.05 Million | 16.18 Million | 15.05 Million | 15.73 Million | 20.92 Million |
| Capital Expenditure | -221 Thousand | -15.46 Million | -272 Thousand | -16 Thousand | -534.43 Thousand |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -7.13 Million | 1.12 Million | -674 Thousand | -87.8 Million | 4.26 Million |
| Free Cash Flow | -90.82 Million | -264 Thousand | -4.09 Million | -84.12 Million | 3.99 Million |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 418 Thousand | 1.52 Million | 5.81 Million | 1.14 Million | 881 Thousand | 664 Thousand |
| Depreciation & Amortization | - | - | 12.94 Million | - | - | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -116.19 Million | - | - | - |
| Other non-cash items | -418 Thousand | -1.52 Million | 7.75 Million | -1.14 Million | -881 Thousand | -664 Thousand |
| Investing Cash Flow | - | - | 1.09 Million | - | - | - |
| Investments in PPE | - | - | -221 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 1.31 Million | - | - | - |
| Financing Cash Flow | - | - | 82.38 Million | - | - | - |
| Debt repayment | - | - | -100.22 Million | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | 97.79 Million | - | - | - |
| Accounts receivables | - | - | 9.38 Million | - | - | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -6.26 Million | - | - | - |
| Other working capital | - | - | 13.47 Million | - | - | - |
| Cash at beginning of period | - | - | 16.18 Million | - | - | - |
| Cash at end of period | - | - | 9.05 Million | - | - | - |
| Capital Expenditure | - | - | -221 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | - | - | -7.13 Million | - | - | - |
| Free Cash Flow | - | - | -90.82 Million | - | - | - |
MICS
4997
600236
NWSZF
CLPR
5673